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The Relationship Between Baseline Blood Pressure and
Computed Tomography Findings in Acute Stroke
Data From the Tinzaparin in Acute Ischaemic Stroke Trial (TAIST)
Gillian M. Sare, MRCP; Philip M.W. Bath, FRCP; Laura J. Gray, PhD; Thierry Moulin, MD;
France Woimant, MD; Timothy England, MRCP; Chamila Geeganage, MSc; Hanne Christensen, MD, PhD;
Peter Paul De Deyn, MD; Didier Leys, MD; Desmond O’Neill, FRCPi; E. Bernd Ringelstein, MD;
for the TAIST Investigators
Background and Purpose—High blood pressure (BP) is present in 80% of patients with acute ischemic stroke and is
independently associated with poor outcome. There are few data examining the relationship between admission BP and
acute CT findings.
Methods—TAIST was a randomized controlled trial assessing 10 days of treatment with tinzaparin versus aspirin in 1489
patients with acute ischemic stroke (48 hr) with admission BP of 220/120 mm Hg. CT brain scans were performed
before randomization and after 10 days. The relationships between baseline BP and adjudicated CT findings were
assessed. Odds ratios per 10 mm Hg change in BP were calculated.
Results—Higher systolic BP (SBP) was associated with abnormal CT scans because of independent associations with
chronic changes of leukoariosis (OR, 1.12; 95% CI, 1.05–1.17) and old infarction (OR, 1.12; 95% CI, 1.06–1.17) at
baseline, and signs of visible infarction at day 10 (OR, 1.06; 95% CI, 1.00–1.13). A lower SBP was associated with
signs of acute infarction (OR, 0.94; 95% CI, 0.89–0.99). Hemorrhagic transformation, dense middle cerebral artery
sign, mass effect, and cerebral edema at day 10 were not independently associated with baseline BP.
Conclusion—Although high baseline BP is independently associated with a poor outcome after stroke, this was not shown
to be through an association with increased hemorrhagic transformation, cerebral edema, or mass effect; trial design may
be suboptimal to detect this. Higher SBP is associated with visible infarction on day 10 scans. The influence of changing
BP in acute stroke on CT findings is still to be ascertained. (Stroke. 2009;40:41-46.)
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High blood pressure (BP) (systolic BP [SBP]140 mm Hg)is present in80% of patients with acute ischemic stroke.1
Multiple studies have shown that high BP is associated
independently with poor outcome,2 including both early death
and late death/dependency. Mechanisms for this relationship
in ischemic stroke include an increased risk of early recur-
rence1,3 and severe cerebral edema.1 Studies of experimental
stroke have shown a relationship between hypertension and
hemorrhagic transformation,4–6 although this was not found
in the International Stroke Trial (IST),1 a trial of 19 435
patients with ischemic stroke.7 To date, there are few pub-
lished studies exploring the relationship between baseline BP
and acute and subacute CT findings in acute stroke;8 CT
findings such as arterial occlusion (hyperdense artery) and
mass effect might be associated with early hypertension.
This study assesses the relationship between blood pres-
sure and CT findings using data from the Tinzaparin in Acute
Ischemic Stroke Trial (TAIST). Previous analysis of the data
from this trial has shown high BP to be associated with poor
outcome.9
Methods
Subjects
TAIST compared the safety and efficacy of tinzaparin (low-
molecular-weight heparin) given at high dose (175 anti-Xa IU/kg per
day) or medium dose (100 anti-Xa IU/kg per day), and aspirin (300
mg od) in patients with acute ischemic stroke.10 Subjects were
included within 48 hours of stroke onset with 47% recruited within
24 hours. Exclusion criteria included significant hypertension (SBP
220 mm Hg or diastolic BP [DBP] 120 mm Hg). All data were
collected prospectively as part of the trial protocol.10
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Blood Pressure
SBP, DBP, and heart rate were measured in all patients on 1 to 6
occasions in the 6 hours leading up to randomization. Mean time to
randomization was 26.1 hours; therefore, measurements of BP were
24 hours after stroke onset. In the present analysis, the baseline
SBP, DBP, and heart rate were calculated from the average of the
first 3 measurements. Further hemodynamic measurements were
calculated as follows: pulse pressureSBPDBP; mean arterial
pressureDBP1/3 pulse pressure; pulse pressure indexpulse
pressure/mean arterial pressure; and rate pressure productSBPheart
rate.
CT Scans
All subjects had a baseline CT scan before randomization. Mean
time from symptom onset to baseline CT was 15.8 hours. A second
CT scan was performed after 10 days of treatment. Each CT scan
was independently adjudicated centrally by 2 radiologists blinded to
treatment and clinical findings. If there was disagreement, then the
scans were reviewed by a third radiologist with the majority decision
standing.
CT Scan Definitions
A scan was defined as abnormal if it showed any abnormality outside
normal anatomic variation. On baseline scans, early signs of hypo-
density were defined as acute infarction; early signs of infarction
were other signs of acute infarction, including loss of gray/white
matter differentiation (contrast reduction) and sulcal effacement.
Dense middle cerebral artery refers to scan evidence of thrombus in
the middle cerebral artery, and hemiedema was edema resulting in
ventricular effacement on the side of the stroke. Leukoariosis was
defined by the presence of periventricular white matter lucency, and
old infarction was defined by the presence of established hypodense
lesions.
On the day 10 scan, evidence of subacute hypodensity in keeping
with ischemic stroke defined infarction evident (1 focus defined as
multiple infarction). Definitions for bleeding parameters in TAIST
were used in MAST-E11 and FISS-bis12 and are as follows: hemor-
rhagic transformation is definite as petechial bleeding within the
infarct; intrainfarct hematoma represents significant confluent bleed-
ing within the infarct; additional hematoma is bleeding unrelated to
the infarct; and interventricular bleeds are adjudicated as blood in
ventricles. The definitions used in this analysis have been described
previously.13,14
Statistical Methods
The relationship between hemodynamic measures and clinical clas-
sifications was assessed using Student t test. The relationship
between hemodynamic measures and CT findings were assessed
using unadjusted (t test) and adjusted (logistic regression) models;
adjustment included age, sex, baseline severity (Scandinavian Stroke
Scale), time to treatment, and treatment allocation (day 10 scan
only). Odds ratios refer to a change in hemodynamic measure by
10 mm Hg. Significance was taken at P0.05, and SD or 95% CI are
given. All analyses were performed using SPSS (version 11.0 for
Mac OS; SPSS Inc).
Results
Subjects
Of 1489 randomized patients, emerging exclusion criteria
prevented treatment in 15 patients and baseline BP was not
recorded in 5 patients; 177 patients had no baseline CT
adjudicated and 168 had no day 10 scan adjudicated. Twenty-
one patients in both the baseline and day 10 scans had
unsatisfactory scan quality; therefore, the information from
these scans is reported variably. As such, the denominator for
the different imaging variables varies. Baseline characteris-
tics of randomized patients in TAIST have been published
previously.10 Mean baseline BP in all randomized TAIST
patients was 156.4 mm Hg (SD, 22.8). Baseline SBP was
significantly related to OCSP clinical subtype;15 LACS pa-
tients had significantly higher SBP than non-LACS patients
(mean SBP 160.1 mm Hg vs 155.0 mm Hg; P0.0001);
TACS patients had significantly lower baseline SBP than
non-TACS patients (mean SBP 154.5 mm Hg vs 157.5 mm Hg;
P0.01). Baseline SBP was also significantly related to
TOAST subtype16 (P0.0001; with mean SBPs for lac-
unar 160.1 mm Hg, large artery153.8, and cardioembolic
154.5 mm Hg).
Baseline Scan
Baseline scan findings were compared with SBP, DBP, mean
arterial pressure, rate pressure product, and pulse pressure.
All of the hemodynamic variables were associated with scan
findings with the exception of DBP. The results for SBP with
odds ratios for the data with and without adjustment for
confounding factors are shown in Table 1. Figure 1 shows
baseline CT findings and mean SBP with standard deviations.
Before adjustment, all of the baseline CT findings were
associated with SBP. Patients with a higher baseline SBP
were more likely to have had an abnormal scan, with this
being related to an increase in leukoariosis and the presence
of old infarction. These associations remained statistically
significant after adjustment. The rest of the baseline CT
findings, including evidence of acute infarction, early signs of
infarction such as loss of gray white matter differentiation,
mass effect, and hemiedema, were more common in patients
with lower BP. With the exception of evidence of acute
infarction, all of these factors ceased to be statistically
significant after adjustment.
Day 10 Scan
Day 10 scan findings were compared with baseline SBP,
DBP, mean arterial pressure, rate pressure product, and pulse
pressure. Once again DBP was not associated with scan
findings. Of the remaining hemodynamic measurements, the
relationship with SBP remained the most consistent. The
results for SBP with odds ratios for the data with and without
adjustment for confounding factors are shown in Table 2.
Figure 2 shows day 10 CT findings and mean baseline SBP
with standard deviations. Patients with higher baseline BP
were significantly more likely to have an infarct (all infarcts
and nonhemorrhagic infarcts) seen on the day 10 scan; this
remained significant after adjustment.
In the trial 435 patients (29%) had evidence of hemor-
rhagic transformation of their infarct, 11 (0.7%) of which
were symptomatic.10 Hemorrhagic transformation (petechial
bleeding within the infarct) was not associated with baseline
BP after adjustment, nor was the amount of petechial bleed-
ing. Larger bleeds forming intrainfarct hematomas, hemato-
mas not related to the infarct, and interventricular bleeds were
less common and were not significantly related to BP.
Patients with symptomatic bleeds had nonsignificantly
higher baseline SBP than those without (165.3 mm Hg, SD
14.6 vs 156.4 mm Hg, SD 22.8) after adjustment for con-
founding factors P0.246. Seventy patients (4.7%) died
before day 10. Twenty of these had adjudicated clinical scans
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performed between day 1 and 10. Of these patients, 14 of 20
(70%) had mass effect evident on CT (P0.0001). The group
who died before day 10 did not have a higher baseline SBP
than those who did not die (157.8 mm Hg vs 156.4 mm Hg;
P0.598).
Discussion
This exploratory analysis of a large, randomized, controlled
trial in acute stroke sought to examine whether the associa-
tion between high BP and poor outcome in stroke is related to
mechanisms visible on CT scan. This study shows that BP
levels at entry into the trial (24 hours after stroke onset) are
associated with CT findings. Early infarction, as visible on
the baseline CT, appears to be independently related to lower
BP. In contrast, other apparent associations between baseline
CT findings and BP (dense middle cerebral artery, he-
miedema, mass effect) disappear after adjustment.
The association between lower BP and evidence of acute
infarction may be related to clinical subtype; therefore, stroke
severity. Data from this study concur with that from IST,
which revealed that patients with a total anterior circulation
strokes (TACS, Oxford Community Stroke Project classifi-
cation15) had lower blood pressures;1 TACS are more likely
to be visible on early CT scans.17 This is in accordance with
Table 1. Relationship Between Hemodynamic Factors and Baseline CT Findings
CT Findings at Baseline
N of Patients Finding
Present/Absent/Missing
SBP OR (95% CI)
Unadjusted
SBP OR (95% CI)
Adjusted
Abnormal scan 736/560/190 1.13 (1.07–1.18) 1.09 (1.03–1.15)
Acute infarction 395/898/193 0.90 (0.87–0.96) 0.94 (0.89–0.99)
Early signs of infarction 157/1137/192 0.90 (0.83–0.97) 0.94 (0.87–1.02)
Contrast reduction 151/1115/220 0.91 (0.84–0.98) 0.95 (0.88–1.03)
Lentiform nucleus involvement 96/1172/218 0.91 (0.78–0.94) 0.90 (0.81–0.99)
Insular zone involvement 95/1172/219 0.84 (0.77–0.93) 0.90 (0.82–1.00)
Dense MCA 64/1191/1255 0.82 (0.73–0.91) 0.87 (0.78–1.00)
Hemioedema 148/1127/211 0.87 (0.82–1.00) 0.93 (0.87–1.00)
Mass effect 75/1219/192 0.87 (0.78–1.00) 0.92 (0.83–1.00)
Leukoariosis 597/696/193 1.15 (1.09–1.21) 1.12 (1.05–1.17)
Old infarctions 483/811/192 1.14 (1.07–1.20) 1.12 (1.06–1.17)
ORs are for each 10-mm Hg change in BP.
MCA indicates middle cerebral artery.
Controlled for age, sex, baseline Scandinavian stroke scale, and time to treatment.
P0.05 are shown in bold.
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Figure 1. Stock chart showing baseline SBP (mean, SD) in baseline scan by type of abnormality. The BP scale shows the top end of
the BP scale and does not cross the x-axis at 0. SD bars; *significant before adjustment; **significant after adjustment; MCA, middle
cerebral artery.
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the observation that patients with early signs of acute infarc-
tion had a lower BP in this analysis. Low BP is also
associated with poor outcome after stroke after adjustment for
stroke severity.1 This may be because of concurrent medical
problems (cardiac failure, sepsis), or it may be hypothesized that
low perfusion pressure in the ischemic penumbra causes it to
develop into frank infarction.
Additionally, a key confounding variable is time between
ictus and scan because BP declines progressively from stroke
onset over the first hours and days.18 CT findings in acute
ischemic stroke take time to develop after clinical presenta-
tion so it may be that the lower BP seen with some CT
features are explained by longer ictus to scan times; statistical
adjustment may not completely control for this.
Analysis of the TAIST data provide some insights into the
association between BP and poor outcome. Although the link
between high BP and poor outcome after stroke is well-
established, the explanation for this relationship remains unclear.
Suggested mechanisms include increased recurrence,1,9 fatal
cerebral edema,1 and increased hemorrhagic transformation.4–6
Table 2. Relationship Between Hemodynamic Factors and Day 10 CT Findings
CT Findings at Day 10
N of Patients Finding
Present/Absent/Missing
SBP OR ( 95% CI)
Unadjusted
SBP OR (95% CI)
Adjusted
Abnormal scan 367/930/189 0.98 (0.93–1.04) 0.99 (0.99–1.00)
Infarction evident 912/383/191 1.02 (0.96–1.07) 1.06 (1.00–1.13)
Nonhemorrhagic infarction 483/815/188 1.08 (1.03–1.14) 1.08 (1.03–1.14)
Hemorrhagic infarction 435/862/189 0.93 (0.87–0.98) 0.96 (0.91–1.02)
Petechial bleeding 50% 143/286/6 1.04 (0.95–1.14) 1.04 (0.94–1.15)
Intrainfarct hematoma 14/1284/188 0.99 (0.79–1.24) 0.98 (0.77–1.23)
Additional hematoma 1/1278/207 0.96 (0.40–2.30) 1.06 (0.46–2.45)
Blood in ventricles 4/1275/207 0.92 (0.60–1.42) 0.90 (0.59–1.38)
Total superficial bleed 48/449/NA 1.03 (0.90–1.17) 1.07 (0.94–1.20)
Partial superficial bleed 343/120/NA 0.95 (0.90–1.00) 0.97 (0.91–1.02)
Deep bleed 237/212/NA 0.93 (0.88–0.99) 0.96 (0.90–1.03)
Multiple infarcts 14/1264/208 0.89 (0.71–1.13) 0.90 (0.71–1.15)
Mass effect 215/1063/208 0.94 (0.88–1.00) 0.98 (0.91–1.06)
Midline shift 23/1254/209 0.90 (0.76–1.10) 1.01 (0.83–1.20)
ORs are for each 10-mm Hg change in BP.
Controlled for age, sex, baseline Scandinavian stroke scale, time to treatment, and treatment group.
P0.05 are shown in bold.
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Figure 2. Bar chart showing baseline SBP (mean, SD) in day 10 scan by type of abnormality. The BP scale shows the top end of the
BP scale and does not cross the x-axis at 0. SD bars; *significant before adjustment; **significant after adjustment.
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Analysis of the TAIST data based on day 0 and 10 CT
scans does not reveal a significant association between
hypertension and cerebral edema, which was present on 11%
of baseline scans. In contrast, data from IST reported a
possible relationship between BP and fatal (presumed) cere-
bral edema; in IST, the outcome of fatal cerebral edema was
derived and not dependent on clinical or imaging data.1 A
case-control analysis of patients with ischemic stroke re-
vealed a relationship between fatal cerebral edema and
12-hour systolic hypertension,19 although this does not prove
causality. The cerebral edema may have caused an increase in
BP through a Cushing response or, alternatively, been a
consequence of raised BP caused by vasoconstriction and
breakdown of the blood–brain barrier.
One explanation for the current findings is the timing of the
CT scans. Baseline scans were performed on average 15
hours after stroke onset at a time that may be too early to
detail many cases of cerebral edema. Similarly, scans at day
10 may also miss the peak incidence of cerebral edema, and
70 patients with severe stroke died before day 10. This is
supported by data from 20 of these 70 patients who had an
adjudicated clinical scan before death; in this group, early
death was strongly associated with the presence of mass
effect, although the number was too small to confirm an
association with SBP. Another explanation is that exclusion
of patients with hemorrhagic transformation on baseline scan
from enrollment in the trial. This will have excluded the most
severe strokes and, therefore, those most prone to cerebral
edema.
Analysis of the TAIST data also fails to confirm experi-
mental studies that show a link between baseline hyperten-
sion and hemorrhagic transformation of the infarction.4–6
Although patients with hemorrhage on baseline scan were
excluded from TAIST, one-third of patients had evidence of
hemorrhagic transformation (defined as petechial bleeding
within the infarct) at day 10. There was no evidence of an
association between baseline BP and subsequent hemorrhagic
transformation or amount of petechial bleeding. There were
no significant associations between more clinically relevant
bleeds (hematoma formation, interventricular bleeds or symp-
tomatic bleeds) and BP, although less of these events oc-
curred, reducing statistical power. Analysis of IST also failed
to show a link between BP and hemorrhagic transformation.1
However, this analysis cannot provide information on the
relationship between BP at onset and hemorrhagic transfor-
mation in the hyperacute phase of ischemic stroke, because
patients with early evidence of hemorrhagic transformation
were excluded from this trial. Further information from
hyperacute studies are needed to examine effects of BP in the
first few hours after onset. A recent retrospective analysis of
386 placebo-treated patients in the ECASS II thrombolysis
trial did not show an association between baseline BP (taken
within 6 hours) and hemorrhagic transformation.8
The presence of leukoariosis and old infarctions are sig-
nificantly associated with high BP at baseline. These imaging
changes are chronic and will have antedated the index event.
TAIST confirms earlier studies showing a link between high
BP, leukoariosis, and recurrent infarction.20–22
At day 10, the only CT finding that was associated with
high BP after adjustment was the presence of a visible
infarction. Statistical adjustment included baseline severity,
so the presence of this visible CT lesion is not primarily
related to the severity of the presenting stroke. This may be
because most strokes were lacunar (42% in the TAIST trial
using a modified version of the TOAST classification16) and,
whereas these strokes are less likely to be visible acutely, they
are associated with leukoariosis and past history of hyperten-
sion, which are associated with high baseline BP.9 It may also
be that patients with long-standing hypertension, who are
more likely to have a higher BP in the days after stroke onset,
have more severe atherosclerosis, and, therefore, more severe
infarcts.
Although the findings on the relationship between baseline
BP and early CT findings are novel, there are several
limitations to this study. Importantly, the data come from a
randomized controlled trial with specific inclusion–exclusion
criteria so that selection bias will be present inherently. In
particular, patients with a very high BP (BP 220/
120 mm Hg) were excluded from the trial; therefore, there are
no data on severely hypertensive patients who may have
significant CT findings. However, IST showed patients with
SBP over 170 mm Hg to have worse outcomes, and previous
analysis TAIST trial data shows hypertension to be related to
poor outcome.1 Additionally, patients with hemorrhagic
transformation on baseline scan were excluded, which will
have led to an underrepresentation of patients with very
severe stroke. Finally, CT scans at day 10 may have missed
some infarcts caused by “fogging.”23 However, 912 of 1484
patients had evidence of infarct at day 10, so this problem
appears to be minimal. Nevertheless, the data come from a
large, high-fidelity, double-blinded, double-dummy trial, and
the nature of the trial with blinded adjudication of CT scans
and blinding to treatment arrangement makes analysis of BP
and CT findings robust. This article does not address outcome
in patients with elevated BP in the TAIST trial, because this
has already been assessed and published.9 This analysis was
designed to assess possible mechanisms from CT findings
rather than outcome.
Overall, this analysis provides insight into the association
between baseline BP and CT findings in acute and subacute
stroke. Although we have not shown cerebral edema or
hemorrhagic transformation to be related to BP, patients with
elevated SBP are more likely to have visible infarctions by
day 10, an intermediate explanation for a poor functional
outcome. This is an exploratory analysis, and as such there
can be no firm recommendations for the treating physician
regarding hypertension in acute ischemic stroke. There are
currently large-scale ongoing trials in this area (SCAST and
ENOS24) which should provide robust data on which to base
clinical practice, as well as the opportunity to prospectively
analyze CT data in relation to BP, including the influence of
changing BP in acute stroke.
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